Cargando…
1681P First results of the COCO study: COVID-19 outcomes in patients with cancer
Autores principales: | Seguí, E., García de Herreros, M., Auclin, E., Mirallas, O., Casadevall, D., Rodriguez, M., Epaillard, N., Tagliamento, M., Pilotto, S., López-Castro, R., Mielgo, X., Urbano, C., Pesántez, D., Saoudi, N., Bluthgen, M.V., Masfarré, L., Minatta, J.N., Cruz, C.A., Mezquita, L., Prat, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506441/ http://dx.doi.org/10.1016/j.annonc.2020.08.1745 |
Ejemplares similares
-
1713P Active smoking and severity of COVID-19 infection in cancer patients
por: Marta, G.D.H., et al.
Publicado: (2020) -
1714P Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score
por: Seguí, E., et al.
Publicado: (2020) -
P1.12-04 The FLARE score and circulating neutrophils are associated with poor Covid-19 outcomes in patients with thoracic cancers
por: Seguí, E., et al.
Publicado: (2022) -
1726P Expanding the role of medical oncologist in the management of COVID-19
por: Ghiglione, L., et al.
Publicado: (2020) -
P09.15 Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19
por: Fernández-Mañas, L., et al.
Publicado: (2021)